Transcutaneous Electrical Nerve Stimulation Market Growth & Trends
The global transcutaneous electrical nerve stimulation market is anticipated to reach USD 419.48 million by 2030, and is expected to expand at a CAGR of 3.84% from 2022 to 2030 according to a new report by Grand View Research, Inc. Rising cases of chronic pain, sports injuries, along with an increasing geriatric population base are some of the major factors driving transcutaneous electrical nerve stimulation market growth. For instance, as per a CDC report, in 2019, 20.4% of adults had chronic pain and 7.4% of adults had high impact chronic pain (limited work activities) in the U.S.
Moreover, the growing preference for TENS among physiotherapists is further aiding in the market growth. Physiotherapists are increasingly shifting their preference from manual techniques to muscle stimulators to treat patients in clinical and at-home settings as they consume less time and are more effective. This is expected to drive the transcutaneous electrical nerve stimulation growth over the forecast period.
The outbreak of COVID-19 in the year 2020 has moderately hampered the market expansion owing to the issues such as the disruption of the medical supply chain, delayed production, and a restricted workforce. However, the introduction of the COVID-19 vaccine, and the lifting of lockdown impositions across the borders, are expected to have a positive impact on the transcutaneous electrical nerve stimulation market in the coming years.
Request a free sample copy or view the report summary:
Transcutaneous Electrical Nerve Stimulation Market Report
Transcutaneous Electrical Nerve Simulation Market Report Highlights
- Based on product type, the portable segment dominated the market with a revenue share of 71.70% in 2021 and is anticipated to witness the highest CAGR of 4.0% during the forecast period. Portable TENS would decrease the number of doctor visits for patients, therefore are anticipated to support market growth over the forecast period.
- Based on application, the chronic pain segment is likely to witness the fastest growth in the forecast period, owing to the growing prevalence of chronic pain, especially amongst senior citizens.
- Based on end-use, physiotherapy clinics dominated the market. The growing preference of physiotherapists toward electrotherapy as compared to manual techniques is a major factor driving the growth of this segment.
- On the other hand, the home healthcare segment is anticipated to witness the fastest growth of a CAGR of 4.9% over the forecast period.
- North America dominated the market with the highest revenue share of 43.91% in 2021 owing to the presence of key participants, and the high purchasing power of consumers.
Some of the prominent players operating in the transcutaneous electrical nerve stimulation market are:
- OMRON Corporation
- Zynex Medical
- NeuroMetrix, Inc.
- EMS Physio Ltd.
- BioMedical Life Systems
- DJO Global, Inc.
- Globus
